COVID-19大流行期间造血细胞移植的现实问题和潜在解决方案:来自全球血液和骨髓移植网络和国际血液和骨髓移植研究中心卫生服务和国际研究委员会的观点

IF 4.3 Q1 Medicine

Biology of Blood and Marrow Transplantation Pub Date : 2020-12-01 DOI:10.1016/j.bbmt.2020.07.021

Ghada Algwaiz , Mahmoud Aljurf , Mickey Koh , Mary M. Horowitz , Per Ljungman , Daniel Weisdorf , Wael Saber , Yoshihisa Kodera , Jeff Szer , Dunia Jawdat , William A. Wood , Ruta Brazauskas , Leslie Lehmann , Marcelo C. Pasquini , Adriana Seber , Pei Hua Lu , Yoshiko Atsuta , Marcie Riches , Miguel-Angel Perales , Nina Worel , Shahrukh K. Hashmi

{"title":"COVID-19大流行期间造血细胞移植的现实问题和潜在解决方案:来自全球血液和骨髓移植网络和国际血液和骨髓移植研究中心卫生服务和国际研究委员会的观点","authors":"Ghada Algwaiz , Mahmoud Aljurf , Mickey Koh , Mary M. Horowitz , Per Ljungman , Daniel Weisdorf , Wael Saber , Yoshihisa Kodera , Jeff Szer , Dunia Jawdat , William A. Wood , Ruta Brazauskas , Leslie Lehmann , Marcelo C. Pasquini , Adriana Seber , Pei Hua Lu , Yoshiko Atsuta , Marcie Riches , Miguel-Angel Perales , Nina Worel , Shahrukh K. Hashmi","doi":"10.1016/j.bbmt.2020.07.021","DOIUrl":null,"url":null,"abstract":"<div><p>The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine.</p><p>© 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.</p></div>","PeriodicalId":9165,"journal":{"name":"Biology of Blood and Marrow Transplantation","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbmt.2020.07.021","citationCount":"40","resultStr":"{\"title\":\"Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee\",\"authors\":\"Ghada Algwaiz , Mahmoud Aljurf , Mickey Koh , Mary M. Horowitz , Per Ljungman , Daniel Weisdorf , Wael Saber , Yoshihisa Kodera , Jeff Szer , Dunia Jawdat , William A. Wood , Ruta Brazauskas , Leslie Lehmann , Marcelo C. Pasquini , Adriana Seber , Pei Hua Lu , Yoshiko Atsuta , Marcie Riches , Miguel-Angel Perales , Nina Worel , Shahrukh K. Hashmi\",\"doi\":\"10.1016/j.bbmt.2020.07.021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine.</p><p>© 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.</p></div>\",\"PeriodicalId\":9165,\"journal\":{\"name\":\"Biology of Blood and Marrow Transplantation\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2020-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.bbmt.2020.07.021\",\"citationCount\":\"40\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biology of Blood and Marrow Transplantation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1083879120304547\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biology of Blood and Marrow Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1083879120304547","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 40

摘要

当前由SARS-CoV-2引起的COVID-19大流行，对发达国家和发展中国家造血细胞移植(HCT)的许多方面都产生了影响。认识到此次大流行对HCT中心日常工作的影响所带来的挑战，以及认识到世界范围内实践的差异，世界血液和骨髓移植网络(WBMT)和国际血液和骨髓移植研究中心(CIBMTR)卫生服务和国际研究委员会联合编写了一份专家意见声明，作为处理HCT某些方面的一般指南。包括HCT接受者的SARS-CoV-2诊断、HCT前后的管理、捐赠者问题、医疗旅游和设施管理。在这些可能持续数月或数年的关键时期，HCT社区必须重新组织，对那些迫切需要移植的患者进行移植活动，尽管要非常谨慎。在缺乏高质量循证医学的情况下，这种共享的知识可能对HCT社区有价值。©2020美国移植和细胞治疗学会。Elsevier Inc.出版。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee

查看原文本刊更多论文

The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Biology of Blood and Marrow Transplantation 医学-免疫学

CiteScore

6.60

自引率

0.00%

发文量

1061

审稿时长

3-6 weeks

期刊介绍： Biology of Blood and Marrow Transplantation publishes original research reports, reviews, editorials, commentaries, letters to the editor, and hypotheses and is the official publication of the American Society for Transplantation and Cellular Therapy. The journal focuses on current technology and knowledge in the interdisciplinary field of hematopoetic stem cell transplantation.